Kim Young-jin appointed new CEO in Korea's Sanofi-Aventis

Published: 2004-09-09 06:57:00

Updated: 2004-09-09 06:57:00

Kim Young-jin, Vice chairman of Handok-Aventis Pharma, is appointed a new chief executive officer of Sanofi-Aventis in Korea, and a new Chief Operating Officer Steve Oldfield, regional manager of Sanofi-Synthelabo in Thailand, will be in charge of Pharmaceutical Operations in Asia.

Sanofi-Ave...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK